Bulletin

Pharma groups to pay NHS £550m 'rebate'

NHS benefit from rebate

The National Health Service is to receive a £550m 'rebate' from the pharmaceuticals industry next year as part of a deal that drugmakers hope will spur faster adoption of new medicines in Britain. Pharma companies will pay the sum under an agreement that caps growth in the NHS budget for branded drugs, with the industry reimbursing any spending that overruns the cap. Almost £1bn has been paid since the deal was struck in 2013; this week pharma companies reached an agreement with the Department of Health to pay £550m in 2016. The sum includes £200m brought forward from the estimated rebates that would have been due in 2017 and 2018. The Association of the British Pharmaceutical Industry said it hoped the upfront payment would help overcome hurdles to the adoption of new medicines.

 

Note: News bulletin content has been provided by a third-party and is not the opinion of Santander

Other Articles

GoJumpIn

The sky is seemingly the limit for a company which has got us all jumping with excitement as they secure a Santander funding deal to make…

Bulletin
Food and drink exporting opportunities in the UAE

Richard Cuda, Director - Strategic Banking Alliances, International, Santander UK says UK food and drink manufacturers should seriously…

Bulletin

According to DIT, of the 2.5 million businesses registered in the UK, an estimated 360,000 who have an exportable product or service…

Bulletin
Food and drink exporting opportunities in the UAE

Richard Cuda, Director - Strategic Banking Alliances, International, Santander UK says UK food and drink manufacturers should seriously…

Bulletin

According to DIT, of the 2.5 million businesses registered in the UK, an estimated 360,000 who have an exportable product or service…

Bulletin
Cardiff-based Forward Waste Management

Money will support the company, which serves the manufacturing sector, with Welsh and West Midland growth plans.

Bulletin

Where Next?